PREDICT Therapy Selection for JAK, T-cell, or IL-6 Inhibitor Therapies Using a Molecular Signature Response Classifier (PREDICT)

NCT06390709 · clinicaltrials.gov ↗
UNKNOWN
Status
1100
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Scipher Medicine